Biofunctionalized Decellularized Tissue-Engineered Heart Valve with Mesoporous Silica Nanoparticles for Controlled Release of VEGF and RunX2-siRNA against Calcification

The goal of tissue-engineered heart valves (TEHV) is to replace normal heart valves and overcome the shortcomings of heart valve replacement commonly used in clinical practice. However, calcification of TEHV is the major bottleneck to break for both clinical workers and researchers. Endothelializati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Wenpeng, Zhu, Xiaowei, Liu, Jichun, Zhou, Jianliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376836/
https://www.ncbi.nlm.nih.gov/pubmed/37508886
http://dx.doi.org/10.3390/bioengineering10070859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376836/
https://www.ncbi.nlm.nih.gov/pubmed/37508886
http://dx.doi.org/10.3390/bioengineering10070859

Ejemplares similares